View in Browser
New Test: Lipid Panel, Non-Fasting (LIPSC2)
Effective immediately, the Department of Pathology & Laboratory Medicine will offer separate lipid panels to distinguish between fasting and non-fasting patients:
  • Lipid Panel, Fasting (LIPSCN)
  • Lipid Panel, Non-fasting (LIPSC2)
Current guidelines on the management of blood cholesterol and dyslipidemia recommend either a fasting or non-fasting lipid profile for estimating arteriosclerotic cardiovascular disease risk (ASCVD), and documenting baseline LDL-C prior to therapy. However, fasting lipid panels are still recommended as a follow up for adult patients in whom an initial non-fasting lipid profile reveals a triglyceride level of 400 mg/dL or greater, and are also reasonable as an initial evaluation for patients with a family history of premature ASCVD or genetic hyperlipidemia. For non-fasting panels, it may be prudent to counsel patients to avoid ingesting an extremely high-fat meal in the preceding 8 hours prior to testing.

All reports (fasting and non-fasting) will retain National Lipid Association classifications for cholesterol and triglyceride levels. However, results should be considered in context with other risk factors.
Effective date: Immediately

Specimen requirement and testing information:

Specimen: Plasma or Serum

Test methodology: Quantitative, Enzymatic

Test codes: LIPSCN, LIPSC2

Minimum stability† (after separation from cells):
Ambient: 8 hours
Refrigerated: 7 days
Frozen: 1 month

† Some tests may have extended stability beyond stated minimum limits. See directory for details.

Turnaround time (TAT):
STAT: 60 minutes
Routine: 2-4 hours
Set Up Days: Daily

Rejection criteria:
Samples that exceed stated stability, unlabeled/mislabeled/mismatched specimens, and specimens submitted in leaking containers.

References: Click here

A summary of all tests offered by our laboratory services can be found here:


Bridgit O. Crews, PhD, DABCC
Clinical Chemistry & Toxicology

Edwin S. Monuki, MD, PhD
Department of Pathology & Laboratory Medicine
© 2019 The Regents of the University of California. All rights reserved. Proprietary and Confidential. For Internal Distribution Only.